News
IRIX
1.640
-4.09%
-0.070
Iridex Corporation Announces Landmark Study on MicroPulse Transscleral Laser Therapy for Glaucoma Treatment
Barchart · 2d ago
Iridex publishes MicroPulse Transscleral Laser Therapy study
TipRanks · 3d ago
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
Barchart · 3d ago
Weekly Report: what happened at IRIX last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at IRIX last week (1202-1206)?
Weekly Report · 12/09 11:22
Weekly Report: what happened at IRIX last week (1125-1129)?
Weekly Report · 12/02 11:22
Iridex CEO Patrick Mercer Joins Board of Directors
TipRanks · 11/26 11:31
Weekly Report: what happened at IRIX last week (1118-1122)?
Weekly Report · 11/25 11:14
Iridex Corporation Confirms Adoption of Local Coverage Determination L37531 for Micro-Invasive Glaucoma Surgery
Barchart · 11/19 17:36
Iridex comments on changing glaucoma reimbursement landscape
TipRanks · 11/19 13:25
IRIDEX CORP: IRIDEX'S CYCLO G6 PRODUCT FAMILY IS UNAFFECTED BY NEW REIMBURSEMENT LIMITATIONS
Reuters · 11/19 13:14
IRIDEX CORP: ENCOURAGED THAT TRANSSCLERAL CYCLOPHOTOCOAGULATION REMAINS UNAFFECTED BY RECENT GLAUCOMA LCD
Reuters · 11/19 13:14
Iridex Comments on Changing Glaucoma Reimbursement Landscape
Barchart · 11/19 07:14
Weekly Report: what happened at IRIX last week (1111-1115)?
Weekly Report · 11/18 11:11
Iridex Leadership Changes and Strategic Appointments
TipRanks · 11/13 22:56
Iridex Corporation’s Q3 2024 Financial Performance Overview
TipRanks · 11/13 04:25
*Iridex: Will Engage With Global Contract Manufacturing Partners to Improve Gross Margins Through Increased Outsourcing >IRIX
Dow Jones · 11/12 22:07
*Iridex: Implemented a Series of Additional Operating Improvements and Cost-Cutting Measures >IRIX
Dow Jones · 11/12 22:07
Weekly Report: what happened at IRIX last week (1104-1108)?
Weekly Report · 11/11 11:24
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
Barchart · 11/04 15:05
More
Webull provides a variety of real-time IRIX stock news. You can receive the latest news about Iridex through multiple platforms. This information may help you make smarter investment decisions.
About IRIX
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.